​Phase4CPH conducts and develops phase IV pharmacoepidemiological studies of clinical importance using state-of-the art methods and contributes to innovation in the field. We develop and optimize private-public partnerships on real life studies and interact with academia on the development of new methods and education within pharmacoepidemiology.​

 Latest scientific papers

Dette kendetegner danskere med avanceret ikke-småcellet lungekræft med KRAS G12C-mutation
Dagens Medicin, 25 May 2023
Article about the results of our project about KRAS G12C mutated non-small cell lung cancer

Trods nær kontakt til sundhedsvæsenet: Selvmordstruede får ikke den rette behandling
Psykiatrisk Tidsskrift, 24 May 2023
Article about the results of our project regarding healthcare utilisation before suicide or suicide attempt​

KRAS G12C mutated advanced non-small cell lung cancer (NSCLC): Characteristics, treatment patterns and overall survival from a Danish nationwide observational register study
Frost, MG; Jensen, KJ; Gotfredsen, DR; Sørensen, AMS; Ankarfeldt, MZ; Louie, KS; et al.
Lung Cancer, February 2023

Kill your darlings: Stop using the terms retrospective and prospective
Ankarfe​ldt, MZ; Osmanski, BI; Blond, K
Pharmacoepidemiology and Drug Safety, February 2023

​Healthcare resource utilization prior to suicide death or suicide attempt in patients with major depressive disorder – a Danish registry-based cohort study
Jensen, KJ; Osler, M; Bødker, N; Riise, J; Petersen, J
Suicide and Life-Threatening Behavior, February 2023

Drug utilization of biologic therapy in Crohn's disease and ulcerative colitis: A population-based Danish cohort study 2015-2020
Jensen, KJ; Jensen, CB; Wennerström, C; Burisch, J; Petersen, J
Scandinavian Journal of Gastroenterology, February 2023​


​See all publications